Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

09 November 2015 : Review article  

Patiromer: Review of a Novel Agent for ­Long-Term Treatment of Hyperkalemia

Neel M. ShahE, Mohamed TelebD, Miraie WardiC, Hasan J. SalamehF

DOI: 10.12659/MSRev.896037

Med Sci Rev 2015; 2:137-142

Abstract

Despite advancements in medicine, hyperkalemia has remained a dangerous electrolyte imbalance disorder without new pharmaceutical agents for chronic treatment. Currently, agents that help treat hyperkalemia are for acute onset, and no long-term treatments with sufficient efficacy and safety are available. This review examines patiromer, which is currently pending U. S. Food and Drug Administration (FDA) approval, regarding ability to decrease mean serum potassium levels in patients with chronic kidney disease (CKD) while taking renin-angiotensin-aldosterone system inhibitors (RAASi). The review will also examine the long-term safety of this drug for potential long-term management. Published articles were found using a national database that pertained only to patiromer and hyperkalemia in CKD patients. We excluded any trials that looked at hyperkalemia in primarily heart failure. The present study takes an in-depth look at how the drug performed in 3 consecutive trials and summarizes them in a single article for reader convenience. Overall, patiromer shows promising evidence in clinical trials to provide a decrease in mean serum potassium and has a relatively mild side effect panel over a chronic treatment phase. Further trials should be performed to test these results over a multiracial and multi gender population.

Keywords: Angiotensin-Converting Enzyme Inhibitors, Hyperkalemia, Renal Insufficiency, Chronic

Add Comment 0 Comments

Editorial

01 September 2023 : Editorial  

Editorial: A Rapid Global Increase in COVID-19 is Due to the Emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.942244

Med Sci Monit 2023; 29:e942244

0:00

In Press

28 Sep 2023 : Clinical Research  

Trends in Hospitalization Duration for Rare Diseases: A Retrospective Analysis of Sarcoidosis, Still's Dise...

Med Sci Monit In Press; DOI: 10.12659/MSM.941536  

27 Sep 2023 : Laboratory Research  

Enhanced Proliferation and Adhesion Marker Gene Expression in Fibroblast Cells: Evaluating the Efficacy of ...

Med Sci Monit In Press; DOI: 10.12659/MSM.941641  

26 Sep 2023 : Clinical Research  

Hypothalamic Injury and Clinical Outcomes in Patients with Post-Traumatic Hyponatremia: A Diffusion Tensor ...

Med Sci Monit In Press; DOI: 10.12659/MSM.942397  

26 Sep 2023 : Clinical Research  

Psychometric Properties of the Polish Version of the FACIT-Sp-12: Assessing Spiritual Well-Being Among Pati...

Med Sci Monit In Press; DOI: 10.12659/MSM.941769  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750